The blood vessel, linchpin of diabetic lesions

Metabolism: Clinical and Experimental

Volumn 48, Issue 3, 1999, Pages 406-409

  Plante, Gérard E ^a,b   Alfred, Jude ^a   Chakir, Mouna ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; HYPERTENSION; INTERSTITIAL FLUID; LYMPHATIC DRAINAGE; MICROALBUMINURIA; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASA VASORUM; VASCULAR DISEASE;

EID: 0032969964     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90094-X     Document Type: Article

References (24)

1. Klein R, Klein BE, Moss SE: Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15:1875, 1992
2. Bojestig M, Arnqvist HJ, Hermansson G, et al: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18, 1994
3. Arbus GS, Fenton SSA, Jeffery JR, et al: Le Registre Canadien des Insuffisances et Transplantations d' Organes. Rapport de la Fondation Canadienne du Rein. Montreal, Canada, National Kidney Foundation, 1987
4. Chakir M, Regoli D, Plante GE: B1 Bradykinin Receptor Blockade May Prevent Diabetic Vascular Morbidity. Amsterdam, The Netherlands, European Dialysis and Transplantation Association, 1996.
5. Chakir M, d'Orleans-Juste P, Plante GE: Neutral endopeptidase inhibition, a new approach in the exploration of diabetic vasculopathy. Eur J Pharmacol 285:11-18, 1995
6. Chakir M, Plante GE: Endothelial cell dysfunction in diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 54:45-51, 1996
7. Parving HH, Rossing N, Sander W: Increased metabolic turnover rate and transcapillary escape of albumin in long-term juvenile diabetics. Scand J Clin Invest 35:59-64, 1975
8. Bank N, Coco M, Aynedjian HS: Galactose feeding causes glomerular hyperfusion: Prevention by aldose reductase inhibition. Am J Physiol 256:F994-F999, 1989
9. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-458, 1991
10. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-417, 1981
11. Plante GE, Chakir M, Lehoux S, et al: Disorders of body fluid balance: A new look into the mechanisms of disease. Can J Cardiol 11:788-802, 1995
12. Wigg H, DeCarlo M, Sibley L, et al: Interstitial exclusion of albumin in rat tissues measured by a continuous infusion method. Am J Physiol 263:H1222-H1233, 1992
13. Asmar RG, Pannier B, Santoni JP, et al: Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 78:941-950, 1988
14. Woerner CA: Vasa vasorum of arteries, their demonstration and distribution, in Lansing AI (ed): The Arterial Wall. Baltimore, MD, Williams & Wilkins, 1959, pp 1-14
15. Lehoux S, Plante GE, Sirois MG, et al: Phosphoramidon blocks big-endothelin-1 but not endothelin-1 enhancement of vascular permeability in the rat. Br J Pharmacol 107:996-1000, 1992
16. Mathiesen ER, Hommel E, Giese J, et al: Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 303:81-84, 1991
17. Mogensen CE: Long-term antihypertensive treatment inhibits progression of diabetic nephropathy. BMJ 285:685-689, 1982
18. Lang J: Über die vaskularization der wand und des einbaugewebes mittelgrossergefässe des unterschenkels. Z Anat Entwick-lungsgeschichte 122:482-488, 1961
19. Schöenenberger F, Müller A: Überdie vaskularization der rinderaortenwand. Helvet Physiol Pharmacol 18:136-142, 1960
20. Wysolmerski RB, Lagunoff D: Involvement of myosin lightchain kinase in endothelial cell retraction. Proc Natl Acad Sci USA 87:16-22, 1990
21. Aukland K, Nicolaysen O: Interstitial fluid volume: Local regulatory mechanisms. Physiol Rev 61:556-643, 1981
22. Comper WD, Laurent TC: Physiological function of connective tissue polysaccharides. Physiol Rev 58:255-315, 1978
23. Caro CG, Lever MJ: Factors influencing arterial wall transport. Biorheology 21:197-202, 1984
24. Colton CK, Friedman S, Wilson DE, et al: Ultrafiltration of lipoproteins through a synthetic membrane. Implications for the filtration theory of atherosclerosis. J Clin Invest 51:2472-2477, 1972